BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 31774955)

  • 1. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial.
    Coralic Z; Kapur J; Olson KR; Chamberlain JM; Overbeek D; Silbergleit R
    Ann Emerg Med; 2022 Sep; 80(3):194-202. PubMed ID: 35718575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: A Randomized Double-blind Controlled Clinical Trial.
    Vignesh V; Rameshkumar R; Mahadevan S
    Indian Pediatr; 2020 Mar; 57(3):222-227. PubMed ID: 32198861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE;
    Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of benzodiazepine-resistant status epilepticus: Systematic review and network meta-analyses.
    Jain P; Aneja S; Cunningham J; Arya R; Sharma S
    Seizure; 2022 Nov; 102():74-82. PubMed ID: 36209676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Home Anticonvulsant Administration for Second-Line Status Epilepticus Treatment.
    Wabl R; Terman SW; Kwok M; Elm J; Chamberlain J; Silbergleit R; Hill CE
    Neurology; 2021 Aug; 97(7):e720-e727. PubMed ID: 34187862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Effectiveness of Levetiracetam Compared to Fosphenytoin in the Treatment of Benzodiazepine Refractory Convulsive Status Epilepticus.
    Nalisetty S; Kandasamy S; Sridharan B; Vijayakumar V; Sangaralingam T; Krishnamoorthi N
    Indian J Pediatr; 2020 Jul; 87(7):512-519. PubMed ID: 32088913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
    BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The established status epilepticus trial 2013.
    Bleck T; Cock H; Chamberlain J; Cloyd J; Connor J; Elm J; Fountain N; Jones E; Lowenstein D; Shinnar S; Silbergleit R; Treiman D; Trinka E; Kapur J
    Epilepsia; 2013 Sep; 54 Suppl 6(0 6):89-92. PubMed ID: 24001084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
    Sathe AG; Mishra U; Ivaturi V; Brundage RC; Cloyd JC; Elm JJ; Chamberlain JM; Silbergleit R; Kapur J; Lowenstein DH; Shinnar S; Cock HR; Fountain NB; Babcock L; Coles LD
    J Clin Pharmacol; 2021 Jun; 61(6):763-768. PubMed ID: 33336359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.
    Nakamura K; Marushima A; Takahashi Y; Kimura A; Asami M; Egawa S; Kaneko J; Kondo Y; Yonekawa C; Hoshiyama E; Yamada T; Maruo K; Inoue Y;
    Trials; 2021 May; 22(1):317. PubMed ID: 33934714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
    Nakamura K; Inokuchi R; Daidoji H; Naraba H; Sonoo T; Hashimoto H; Tokunaga K; Hiruma T; Doi K; Morimura N
    Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children.
    Clay JL; Fountain NB
    Expert Rev Neurother; 2022 Jan; 22(1):1-13. PubMed ID: 34726961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam compared with phenytoin or fosphenytoin in benzodiazepine-refractory pediatric status epilepticus.
    Long B; Gottlieb M
    Acad Emerg Med; 2022 Jan; 29(1):125-127. PubMed ID: 33999500
    [No Abstract]   [Full Text] [Related]  

  • 19. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.
    Cruickshank M; Imamura M; Booth C; Aucott L; Counsell C; Manson P; Scotland G; Brazzelli M
    Health Technol Assess; 2022 Mar; 26(20):1-76. PubMed ID: 35333156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE; Yuksel Karatoprak E; Yilmaz S
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.